PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
These metrics indicate whether the stock trades cheaply or expensively relative to its fundamentals. Value investors use them to find mispricings—buying stocks that appear undervalued, with solid long-term prospects and limited downside risk.
-8.13
Negative P/E while Healthcare median is -3.21. Seth Klarman would scrutinize path to profitability versus peers.
21.12
P/S exceeding 1.5x Healthcare median of 12.88. Jim Chanos would check for potential multiple compression risks.
1.77
P/B less than half the Healthcare median of 3.61. Joel Greenblatt would investigate if assets are truly impaired. Check ROE versus peers.
-109.61
Negative FCF while Healthcare median P/FCF is -11.02. Seth Klarman would investigate cash flow improvement potential.
-644.02
Negative operating cash flow while Healthcare median P/OCF is -7.26. Seth Klarman would investigate operational improvement potential.
1.77
Fair value ratio less than half the Healthcare median of 3.62. Joel Greenblatt would investigate if this discount is justified.
-3.07%
Negative earnings while Healthcare median yield is -0.75%. Seth Klarman would investigate path to profitability.
-0.91%
Negative FCF while Healthcare median yield is -0.34%. Seth Klarman would investigate cash flow improvement potential.